Tamoxifen citrate Prescribing at THE DE PARYS GROUP
Sex hormones and hormone antagonists in malignant disease | Malignant Disease and Immunosuppression
Items (12m)
380
Total Quantity
16.2K
NHS Cost
£1.4K
vs National Avg
+361.4%
THE DE PARYS GROUP prescribed 380 items of Tamoxifen citrate over the last 12 months at a cost of £1,370 to the NHS. This is 361.4% above the national average prescribing rate. Tamoxifen citrate is classified under Sex hormones and hormone antagonists in malignant disease in the BNF.
Monthly Prescribing Trend
Jun 2026
37
Jun 2026
35
Jun 2026
32
Jun 2026
39
Jun 2026
31
Jun 2026
37
Jun 2026
26
Jun 2026
38
Jun 2026
31
Jun 2026
26
Jun 2026
26
Jun 2026
22
Prescribing Details
| Total Items | 380 |
|---|---|
| Total Quantity | 16,217 |
| Total NHS Cost | £1,370 |
| Presentations | 2 different forms |
| vs National Average | +361.4% |
Tamoxifen citrate Prescribing Comparison
| This practice | 380 items |
|---|---|
| National average per practice | 82 items |
| Difference | +361.4% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.